Back to Journals » Cancer Management and Research » Volume 12

Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer [Retraction]

Authors Ding Y, Li X, Zhang Y, Zhang J 

Received 9 November 2020

Accepted for publication 9 November 2020

Published 16 November 2020 Volume 2020:12 Pages 11675—11676


Ding Y, Li X, Zhang Y, Zhang J. Cancer Manag Res. 2020;12:1281—1292.

The Editor and Publisher of Cancer Management and Research wish to retract the published article.

The journal was notified of discrepancies in Table 2 for the Depth of invasion numbers reported. The total number of cases was reported as 70, however the number of cases recorded for the Relative CASC 9 Expression (n = 29 (Low); n = 41 (High)) was inconsistent with the grouping values provided (n = 34 (Low); n = 36 (High)). The authors were unable to provide a satisfactory explanation for this discrepancy and were also unable to provide satisfactory raw data for the study reported.

The editor determined the findings of the study were no longer valid and requested for the article to be retracted.

The authors wish to apologise for this error.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.